|
Vaccine Detail
Rabies DNA Vaccine encoding Rabies virus Glycoprotein |
Vaccine Information |
- Vaccine Name: Rabies DNA Vaccine encoding Rabies virus Glycoprotein
- Target Pathogen: Rabies virus
- Target Disease: Rabies
- Vaccine Ontology ID: VO_0011553
- Type: DNA vaccine
- Status: Research
- G
gene engineering:
- Type: DNA vaccine construction
- Description:
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000251
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Vaccination Protocol: For the intramuscular route, mice were vaccinated with 100 µg of endotoxin-free pDNA in 200 µl of PBS/animal in the anterior quadriceps muscle, in the individual groups (DNA vaccine or vector control), 3 times at 3-wk intervals. Control mice were immunized with PBS only (Kaur et al., 2010).
- Challenge Protocol: For challenge studies, immunized mice were inoculated intracerebrally with 20 LD50 of the CVS strain of rabies virus 21 d after the last immunization. The challenged mice were observed for 18 d for symptoms indicative of rabies virus infection (Kaur et al., 2010).
- Efficacy: DNA vaccine imparted partial protection (60%) against challenge with 20 LD(50) of the challenge virus standard (CVS) strain of rabies virus (Kaur et al., 2010).
|
References |
Kaur et al., 2010: Kaur M, Saxena A, Rai A, Bhatnagar R. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2010; 24(1); 173-183. [PubMed: 19741168].
|
|